Literature DB >> 11805177

Morphologic changes in the peritoneal membrane of patients with renal disease.

John D Williams1, Kathrine J Craig1, Nicholas Topley1, Christopher Von Ruhland1, Maureen Fallon1, Geoffrey R Newman1, Ruth K Mackenzie1, Geraint T Williams1.   

Abstract

This study examined the morphologic features of the parietal peritoneal membranes of 130 patients undergoing peritoneal dialysis (PD) and compared them with the features of the peritoneal membranes of normal individuals, uremic predialysis patients, and patients undergoing hemodialysis. The median thickness of the submesothelial compact collagenous zone was 50 microm for normal subjects, 140 microm for uremic patients, 150 microm for patients undergoing hemodialysis, and 270 microm for patients undergoing PD (P < 0.001 for all versus normal subjects). Compact zone thickness increased significantly with the duration of PD therapy [0 to 24 mo, 180 microm (n = 58); 25 to 48 mo, 240 microm (n = 24); 49 to 72 mo, 300 microm (n = 13); 73 to 96 mo, 750 microm (n = 16); >97 mo, 700 microm (n = 19)]. Vascular changes included progressive subendothelial hyalinization, with luminal narrowing or obliteration. These changes were absent in samples from normal subjects but were present in 28% of samples from uremic patients and 56% of biopsies from patients undergoing PD. In the PD group, the prevalence of vasculopathy increased significantly with therapy duration (P = 0.0001). The density of blood vessels per unit length of peritoneum was significantly higher for patients with membrane failure and was correlated with the degree of fibrosis (P = 0.01). For the first time, a comprehensive cross-sectional analysis of the morphologic changes in the peritoneal membranes of patients undergoing PD is provided. The infrequency of fibrosis in the absence of vasculopathy suggests that vasculopathy may predispose patients to the development of fibrosis. This study provides a sufficiently large cohort of samples to allow structure-function relationships to be established, as well as providing a repository of tissue for further studies.

Entities:  

Mesh:

Year:  2002        PMID: 11805177     DOI: 10.1681/ASN.V132470

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  251 in total

1.  Dialysate CA125 levels after 5 years on continuous peritoneal dialysis.

Authors:  Cengiz Candan; Pınar Turhan; Lale Sever; Mahmut Civilibal; Nur Canpolat; Salim Caliskan; Ozgur Kasapcopur; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2011-01-29       Impact factor: 3.714

Review 2.  Mechanisms and interventions in peritoneal fibrosis.

Authors:  Yasuhiko Tomino
Journal:  Clin Exp Nephrol       Date:  2011-09-21       Impact factor: 2.801

3.  Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis.

Authors:  Lars P Kihm; Sandra Müller-Krebs; Julia Klein; Gregory Ehrlich; Laura Mertes; Marie-Luise Gross; Antonysunil Adaikalakoteswari; Paul J Thornalley; Hans-Peter Hammes; Peter P Nawroth; Martin Zeier; Vedat Schwenger
Journal:  J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 10.121

4.  Robot-assisted transvaginal peritoneoscopy using confocal endomicroscopy: a feasibility study in a porcine model.

Authors:  Richard C Newton; David P Noonan; Valentina Vitiello; James Clark; Christopher J Payne; Jianzhong Shang; Mikael Sodergren; Ara Darzi; Guang-Zhong Yang
Journal:  Surg Endosc       Date:  2012-04-26       Impact factor: 4.584

5.  Increased lymphatic vessels in patients with encapsulating peritoneal sclerosis.

Authors:  Tatsuhiro Yaginuma; Izumi Yamamoto; Hiroyasu Yamamoto; Jun Mitome; Yudo Tanno; Keitaro Yokoyama; Takenori Hayashi; Tetsuya Kobayashi; Michiaki Watanabe; Yutaka Yamaguchi; Tatsuo Hosoya
Journal:  Perit Dial Int       Date:  2012-06-01       Impact factor: 1.756

Review 6.  Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions.

Authors:  Anneleen Pletinck; Raymond Vanholder; Nic Veys; Wim Van Biesen
Journal:  Nat Rev Nephrol       Date:  2012-07-10       Impact factor: 28.314

7.  22-Oxacalcitriol prevents progression of peritoneal fibrosis in a mouse model.

Authors:  Misaki Hirose; Tomoya Nishino; Yoko Obata; Masayuki Nakazawa; Yuka Nakazawa; Akira Furusu; Katsushige Abe; Masanobu Miyazaki; Takehiko Koji; Shigeru Kohno
Journal:  Perit Dial Int       Date:  2012-10-02       Impact factor: 1.756

8.  Dialysate cytokine levels do not predict encapsulating peritoneal sclerosis.

Authors:  Catriona Goodlad; Frederick W K Tam; Sohail Ahmad; Gurjeet Bhangal; Bernard V North; Edwina A Brown
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

9.  SAHA Suppresses Peritoneal Fibrosis in Mice.

Authors:  Kumiko Io; Tomoya Nishino; Yoko Obata; Mineaki Kitamura; Takehiko Koji; Shigeru Kohno
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

10.  Alterations of intercellular junctions in peritoneal mesothelial cells from patients undergoing dialysis: effect of retinoic Acid.

Authors:  Carmen Retana; Elsa Sanchez; Alejandro Perez-Lopez; Armando Cruz; Jesus Lagunas; Carmen Cruz; Socorro Vital; Jose L Reyes
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.